- Home
- FGEN vs OPAD Comparison
FGEN vs OPAD Comparison
Compare FGEN & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- OPAD
- Stock Information
- Founded
- FGEN 1993
- OPAD 2015
- Country
- FGEN United States
- OPAD United States
- Employees
- FGEN N/A
- OPAD N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- OPAD Real Estate
- Sector
- FGEN Health Care
- OPAD Finance
- Exchange
- FGEN Nasdaq
- OPAD Nasdaq
- Market Cap
- FGEN 33.5M
- OPAD 25.3M
- IPO Year
- FGEN 2014
- OPAD N/A
- Fundamental
- Price
- FGEN $7.45
- OPAD $1.37
- Analyst Decision
- FGEN Strong Buy
- OPAD Hold
- Analyst Count
- FGEN 1
- OPAD 5
- Target Price
- FGEN $250.00
- OPAD $2.38
- AVG Volume (30 Days)
- FGEN 74.7K
- OPAD 142.8K
- Earning Date
- FGEN 08-05-2025
- OPAD 08-04-2025
- Dividend Yield
- FGEN N/A
- OPAD N/A
- EPS Growth
- FGEN N/A
- OPAD N/A
- EPS
- FGEN N/A
- OPAD N/A
- Revenue
- FGEN $6,996,000.00
- OPAD $794,159,000.00
- Revenue This Year
- FGEN N/A
- OPAD N/A
- Revenue Next Year
- FGEN N/A
- OPAD $40.79
- P/E Ratio
- FGEN N/A
- OPAD N/A
- Revenue Growth
- FGEN N/A
- OPAD N/A
- 52 Week Low
- FGEN $4.50
- OPAD $0.91
- 52 Week High
- FGEN $38.25
- OPAD $5.13
- Technical
- Relative Strength Index (RSI)
- FGEN 60.54
- OPAD 70.23
- Support Level
- FGEN $5.37
- OPAD $0.91
- Resistance Level
- FGEN $5.73
- OPAD $1.59
- Average True Range (ATR)
- FGEN 0.49
- OPAD 0.13
- MACD
- FGEN 0.27
- OPAD 0.06
- Stochastic Oscillator
- FGEN 83.80
- OPAD 77.94
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.